AzTrials
AzTrials

StrokeNCT02100306

The Role of Auditory Feedback in Guiding Upper Extremity Movements

A study testing Auditory Feedback 100% and Auditory Feedback 50% alternate in people with Stroke, run by Sunnybrook Health Sciences Centre at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Stroke is one of the leading causes of disability, with an estimated prevalence of 50,000 cases per year in Canada. Less than half of stroke patients regain use of their arm and hand. Read more about this study

Who is it for?
Ages 30 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Stroke
What is being tested?
Auditory Feedback 100% and Auditory Feedback 50% alternate
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteCanada
Study dates
May 2014to Sep 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Unilateral first time MCA ischemic stroke
  • Stroke patients should have some movement of shoulder/elbow (no movement of hand - e.g. hand, fingers - is OK)
  • > 2 months post
  • between 30-85 years

Who cannot join

  • prior stroke
  • severe comprehension (or cognitive) deficit that compromises informed consent or understanding of instructions
  • contraindications to MRI (e.g. claustrophobia, metal implants)
  • neurodegenerative or psychiatric disease
  • apraxia
  • auditory deficits that would impair testing
  • prior musculoskeletal injury to back or upper extremity (including shoulder subluxation from stroke)
  • skin conditions that would preclude taping of goniometers

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, M4N 3M5

Other trials in Canada

About this study

Stroke is one of the leading causes of disability, with an estimated prevalence of 50,000 cases per year in Canada. Less than half of stroke patients regain use of their arm and hand. There is currently no intervention regime that is the gold standard, despite the variety of therapeutic techniques used to treat the upper extremity post-stroke. The use of external feedback to improve motor learning is a technique that has been less studied but shows promise. Therefore, the purpose of this proof of principle study it to test whether different auditory feedback frequencies can facilitate reaching ability in people with stroke. In addition brain scans will be collected that will enable us to determine how stroke severity may impact on one's ability to improve with this technique.

We hypothesize that patients who receive less feedback (50% alternate) will have enhanced learning relative to the patients who receive more feedback (100%).

Conditions
Stroke
Being tested
Auditory Feedback 100%, Auditory Feedback 50% alternate
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Auditory Feedback 100%Behavioural

    Patients will receive constant auditory feedback across training trials.

  • Auditory Feedback 50% alternateBehavioural

    Patients will receive alternating auditory feedback (1 trial auditory feedback; 1 trial no auditory feedback) across trials

Study groups in NCT02100306
Study groupRoleWhat they receive
PatientsExperimentalPatients will receive: Auditory Feedback 100% Auditory Feedback 50% alternate
Receives: Behavioral: Auditory Feedback 100%; Behavioral: Auditory Feedback 50% alternate

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in movement error from baseline

    Measured: participants will be followed for the duration of the study, an expected 3 hours per day for 2 weeks (5 days per week/10 days total)

Secondary outcomes (2)
  1. Change in range of motion

    Measured: participants will be followed for the duration of the study, an expected 3 hours per day for 2 weeks (5 days per week/10 days total)

  2. Change in movement duration

    Measured: participants will be followed for the duration of the study, an expected 3 hours per day for 2 weeks (5 days per week/10 days total)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Mar 2014 (estimated)
  2. Study startMay 2014
  3. Primary completionSep 2015 (estimated)
  4. Study completionSep 2015 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
26 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02100306
Sponsor's protocol ID
JCH-1234-SF
Status last verified
Mar 2014
First submitted
14 Mar 2014
Last updated
31 Mar 2014
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Auditory Feedback 100% and Auditory Feedback 50% alternate in people with Stroke, run by Sunnybrook Health Sciences Centre at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Mar 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tea Lulic, MSc (416 480-6100 ext. 85405, tlulic@sri.utoronto.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in movement error from baseline (time frame: participants will be followed for the duration of the study, an expected 3 hours per day for 2 weeks (5 days per week/10 days total)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in